Skip to main content
GemVax & KAEL Co.,Ltd. logo

GemVax & KAEL Co.,Ltd. — Investor Relations & Filings

Ticker · 082270 ISIN · KR7082270000 KO Manufacturing
Open in API
Filings indexed 651 across all filing types
Latest filing 2021-03-16 AGM Information
Country KR South Korea
Listing KO 082270

About GemVax & KAEL Co.,Ltd.

https://gemvax.com/

GemVax & KAEL is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics. Its lead drug candidate is GV1001, a synthetic peptide composed of 16 amino acids, which has demonstrated multiple actions including the modulation of neuroinflammation and reduction of oxidative stress. The company's development pipeline primarily targets neurodegenerative diseases, such as Alzheimer's disease and Progressive Supranuclear Palsy (PSP). Other therapeutic areas under investigation include pancreatic cancer and benign prostatic hyperplasia. GemVax & KAEL is actively advancing its programs through clinical trials to evaluate the efficacy and safety of its novel treatments.

Recent filings

Filing Released Lang Actions
주주총회소집공고
AGM Information Classification · 98% confidence The document is a formal 'Notice of General Meeting of Shareholders' (주주총회소집공고) for GemVax & Kael Co., Ltd. It includes the meeting date, location, agenda items (financial statement approval, director/auditor compensation), and details on electronic voting. It also contains sections on director activities and major shareholder transactions, which are standard components of a proxy statement or notice of meeting in the Korean regulatory context. Since this document serves as the official notification and information package for shareholders to vote on agenda items, it is classified as a Proxy Solicitation & Information Statement.
2021-03-16 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea (often associated with the DART system) used to solicit shareholder votes for an upcoming Annual General Meeting (AGM). It contains the agenda items, proxy solicitation details, and financial statements for the meeting. This falls under the category of Proxy Solicitation & Information Statement.
2021-03-16 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding the scheduling and logistics of an Investor Relations (IR) event (Non-Deal Roadshow). It provides the date, location, purpose, and contact information for the event. Since it is an announcement of an upcoming event rather than the presentation materials themselves, and it does not fit into specific categories like earnings releases or financial reports, it is classified as a Regulatory Filing (RNS) as it serves as a general corporate disclosure.
2021-03-12 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership, and contractual relationships (such as pledges and loans) of major shareholders and their special relations. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2021-03-08 Korean
[기재정정]감사보고서제출(2017사업연도)
Audit Report / Information Classification · 100% confidence The document is a regulatory filing from the Korean Exchange (KRX) system, specifically titled 'Audit Report Submission' (감사보고서 제출) and 'Correction Report' (정정신고). It provides updated financial data (assets, liabilities, equity, profit/loss) following a restatement of consolidated financial statements. While it contains financial data, it is a formal regulatory disclosure of an audit report update rather than the full annual report (10-K) or a standalone audit report (AR). Given the nature of the filing as a regulatory update regarding audit results and financial restatements, it falls under the RNS (Regulatory Filings) category. FY 2017
2021-03-02 Korean
[기재정정]감사보고서제출(2018사업연도)
Audit Report / Information Classification · 100% confidence The document is a regulatory filing from the Korean exchange (KIND) titled 'Audit Report Submission' (감사보고서 제출). It details a correction (정정신고) to a previously submitted audit report due to the restatement of consolidated financial statements. It provides specific financial tables (assets, liabilities, profit/loss) and audit opinions. Since it is a formal regulatory disclosure of financial audit data and corrections, it falls under the 'Audit Report / Information' category. FY 2018
2021-03-02 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.